Essential role for CD103 in the T cell-mediated regulation of experimental colitisCD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic diseaseAutoimmune priming, tissue attack and chronic inflammation - the three stages of rheumatoid arthritisThe expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosisProstaglandin E2 synthesizing enzymes in rheumatoid arthritis B cells and the effects of B cell depleting therapy on enzyme expressionReversal of tolerance induced by transplantation of skin expressing the immunodominant T cell epitope of rat type II collagen entitles development of collagen-induced arthritis but not graft rejection.B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis.Accelerating translational research by clinically driven development of an informatics platform--a case study.Adaptive immunity in rheumatoid arthritis: anticitrulline and other antibodies in the pathogenesis of rheumatoid arthritis.Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides.Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice.Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy.Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis.IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment.Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.Antiphospholipid Antibodies in Lupus Nephritis.Multifunctional T cell reactivity with native and glycosylated type II collagen in rheumatoid arthritisModulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis.Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition.Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositisImplementation of the CDC translational informatics platform--from genetic variants to the national Swedish Rheumatology Quality RegisterImmune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study.Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis.T cells in myositis.Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis.Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients.Mechanisms involved in triggering rheumatoid arthritis.Is rheumatoid arthritis an autoimmune disease?Immunoglobulin characteristics and RNAseq data of FcRL4+ B cells sorted from synovial fluid and tissue of patients with rheumatoid arthritis.The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting.Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis.Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism.CD4+ and CD8+ CD28(null) T Cells Are Cytotoxic to Autologous Muscle Cells in Patients With Polymyositis.
P50
Q24646106-FB751E2E-892E-4E09-AD87-6EEF6E31E7D8Q24805444-4C49C56B-C3C8-4BE3-8406-C05F3F2D9349Q27027441-90C9D1E2-C048-4B2C-86FC-14F3A9A6DCE3Q28740407-C5828E84-5719-40C3-B8B9-4FF03FE28E36Q28743224-D78C53A6-DAA2-4ED1-9052-B9C9E0C6AC72Q30836445-7C3BC473-FD1F-415B-BF85-4BF55DFCC409Q33806313-3427CDA2-2EF4-4BEB-822E-D917532846A9Q34155502-83B47D1E-B7AB-47E2-8285-5BCD1889BC60Q34386498-DB8EF3A0-BBA5-4A9C-A164-1E0B6EE3263BQ34425604-8E5506F5-702D-4F75-A255-287B5F3B6CE6Q34485469-B1B88FCF-3BD8-4B41-8600-261764F2A15EQ34528042-3AC0EE9F-7359-4B05-AFFA-38D1A407D753Q34895182-27338795-089C-43BD-B3D1-CAE9EC2C7CD4Q35008162-5D7142F1-661C-42A3-B5A5-FD90CB4A1A39Q35011877-B946BC1E-FC76-45F8-ACF9-4D46FE3AB772Q35078183-3871C967-5BE5-4BD6-833F-61CF74C9B1D9Q35630042-46EEF397-0CB1-489A-AF9E-115C32AB062EQ36060060-75DF153D-B3B8-4685-BDD6-09BE22C66382Q36069629-A4819D71-DBB9-4096-8B77-57A561688CDFQ36099553-36815B46-CDC5-4BA9-8E8B-6CE4A0CFD2EEQ36401840-3CDBA08E-4C4A-4F0A-A5C1-72DB8BD4B862Q36694143-01AEAE2E-DFD8-4022-B170-25B8F3BE6E23Q36758692-70998660-3169-4201-901B-59F352DD3585Q36758706-601BC6F1-A863-4DDE-814A-FB2E269FF347Q36771917-D4C2B795-85CD-4EBC-96D7-0603928BF07DQ37256337-ADCECB08-92F8-4A4E-8D38-253A1E9F9388Q37465240-5466FF8C-5A9B-451C-B7B6-F6181DB9C612Q37700775-23846D9C-6CC8-406F-B02E-D7AD07B5B2F8Q37849958-FD8280A9-156C-4740-9F55-5984AC81874DQ38070033-8520E503-FF05-461A-93AB-E676C740C344Q38235035-A836B531-667F-4A1A-B171-CBB0960D26EFQ38462400-04943F8D-F02B-4AE5-950C-7576B284FA5FQ38673425-B1D5306C-85F4-4C01-957C-DE6C12F7B52EQ38701152-0EEFE1AA-B533-4B0C-B5E2-1F3023D36273Q38701167-431D17F1-4ACC-4B1F-AB4B-062913A6F3C4Q39029106-9CE2FB04-658D-4225-B2A9-9A05229F885EQ39038694-61A28DBE-3319-4B2A-8DC4-D2ECF79811A5Q39146323-F170F38F-ECDF-491F-8BCE-55BAB3A81E1EQ39838413-695034F3-7195-4513-8750-E52F18B35164Q39983726-3BBFD0B0-1BC7-4E5E-BB60-DCD096E00D29
P50
name
Vivianne Malmström
@ast
Vivianne Malmström
@en
Vivianne Malmström
@es
Vivianne Malmström
@ga
Vivianne Malmström
@nl
Vivianne Malmström
@sl
Vivianne Malmström
@sq
Vivianne Malmström
@sv
type
label
Vivianne Malmström
@ast
Vivianne Malmström
@en
Vivianne Malmström
@es
Vivianne Malmström
@ga
Vivianne Malmström
@nl
Vivianne Malmström
@sl
Vivianne Malmström
@sq
Vivianne Malmström
@sv
prefLabel
Vivianne Malmström
@ast
Vivianne Malmström
@en
Vivianne Malmström
@es
Vivianne Malmström
@ga
Vivianne Malmström
@nl
Vivianne Malmström
@sl
Vivianne Malmström
@sq
Vivianne Malmström
@sv
P21
P27
P31
P569
1966-08-27T00:00:00Z